CO BREATH ANALYSIS MODULE & MONOXOL II— 510(k) K952694

Substantially Equivalent

Bacharach, Inc.

FDA 510(k) clearance K952694 for CO BREATH ANALYSIS MODULE & MONOXOL II, Substantially Equivalent on 1996-01-29. Applicant: Bacharach, Inc..

Clearance details

Applicant
Bacharach, Inc.
Product code
Code CCJ
Advisory panel
Anesthesiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Bethesda, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.